TARE induces heterogeneous dose distributions in both liver tumors and nontumor target liver at a scale below the resolution of nuclear imaging. Although these findings provide insight into microsphere distribution and dose heterogeneity, the clinical significance of fine-scale dose heterogeneity and its potential impact on treatment outcomes remains uncertain and warrants further investigation.
Brekel et al. (Sat,) studied this question.